Viewing Study NCT01328366


Ignite Creation Date: 2025-12-24 @ 4:05 PM
Ignite Modification Date: 2026-01-05 @ 7:54 AM
Study NCT ID: NCT01328366
Status: COMPLETED
Last Update Posted: 2015-07-09
First Post: 2011-04-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Quality of Life and Psychosocial Factors Associated With Severe Psoriasis Following Treatment With Adalimumab
Sponsor: AbbVie (prior sponsor, Abbott)
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: P12-627
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View